Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Let's Talk About Our Feelings!!! -- Ignore unavailable to you. Want to Upgrade?

To: Grainne who wrote (15512)	1/17/1998 7:16:00 AM
From: Ish	Read Replies (1) \| Respond to of 108807

Christine, yes you are confused. There is no law and never has been one on what a biotech could charge for it's products. Remember the $2,000,000,000 conference on healthcare that Hillary led right after Clinton took office? Just before the meetings were to take place, Clinton announced that by presidential edict the government would mandate what drug companies could charge. Unconstitutional and never happened but the result was a scare for biotech investors. Clintons "blind" trust was heavily invested in biotechs. The day before the announcement Hillary called the lady who was in charge of the "blind" trust. Immediately after the call the trust sold all of it's biotech holdings and went short on a number of biotechs. Danged coincidental eh?